Tricor-plc.co.uk2

RNS Number : 2611WTricor PLC26 January 2012 Tricor plc
(“Tricor” or the “Company”)
Issue of Equity, Director Shareholdings, Grant of Options and Total Voting Rights
The Company announces that it is issuing 176,470,587 new ordinary shares of 0.01 of one penny each in the capital of the Company (“Ordinary Shares”) to directors Chan Fook Meng and Nazim Khan. The shares are being issued in satisfaction of unpaid remuneration for services provided to the Company as directors from the date of their appointment to the Board up until 31 December 2011. The shares are being issued at the closing mid-market price on 25 January 2012 of 0.0425p. The directors concerned now hold the fol owing number of shares: *646,000,000 of these shares are held by Jersey Hills Holdings Limited (“Jersey Hills”) a company wholly owned by Chan Fook Meng. Of these 646,000,000 shares, 64,600,000 are held by Jersey Hills on trust for a third party. The Company also announces a further issue of 183,176,470 Ordinary Shares at 0.0425p per share to satisfy other outstanding creditors to the Company.
In addition, the Company has agreed with al the directors that at its discretion it has the option to satisfy their salaries each month through the issue of new Ordinary Shares at the average of the mid-market price for the ten trading days immediately preceding the date on which payment of monthly salaries would otherwise be made. Admission to AIM and Total Voting Rights
Application wil be made for the 359,647,057 new Ordinary Shares to be admitted to trading on AIM (“Admission”) and it is anticipated that Admission wil occur on or around 1 February 2012. The new Ordinary Shares rank pari passu with the Company’s existing ordinary shares of 0.01 of one penny each.
Fol owing Admission the total number of Ordinary Shares in issue wil be 3,737,017,003, each with one voting right and no shares held in treasury. Therefore the total number of voting rights in Tricor wil be 3,737,017,003. This figure may be used by shareholders as the denominator for the calculations by which they wil determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.
Grant of Options
The Company also announces a grant of share options to directors as fol ows: The options have an exercise price of 0.0425 pence per share and can be exercised as fol ows: • One half can be exercised after 25 January 2013; and • One half can be exercised after 25 January 2014.
The options expire on 31 December 2017 and vesting is conditional on the respective person being an employee of the Company at the time. The options become exercisable, inter alia, in the event of an offer for the Company.
The total number of outstanding options over Ordinary Shares in the Company, including those held by former employees but excluding outstanding convertible loan notes, wil now be 1,200,000,000.
Nazim Khan, being the independent director for the purposes of the option grants, having consulted with the Company’s nominated adviser, Al enby Capital Ltd, considers that the terms of the options awards are fair and reasonable insofar as the shareholders of Tricor are concerned.
Al enby Capital Limited (Nominated Adviser and Broker)

Source: http://tricor-plc.co.uk/pdf/Issue%20of%20equity,%20director%20shareholdings,%20grant%20of%20options.pdf

Microsoft word - sevenplaybookpages.docx

                                                                                                                                            WHAT IS SEVEN? SEVEN is 7 weeks worth of outreach minded services and events TELL ME ABOUT THE SEVEN NIGHTS:

Microsoft word - ncscv

Naiomi Chardon Saad Experience Rebexa Group, Inc., San Juan, P.R. Co-Founder and Commercial Director, 2006 to present Assisted in the development of a business plan for an all encompassing consulting firm that would become a one stop shop for compliance services in the region, to better manage the highly diverse needs of regulatory affairs for the Central American market. The

© 2010-2018 PDF pharmacy articles